Arkolith/Insider Trading/IRWD/Form 4

Davis Andrew

SVP, Chief Business OfficerIRONWOOD PHARMACEUTICALS INC (IRWD) · full profile →Form 4 · filed May 22, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$147K
Net Open-Market Flow
-$147K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 20, 2024Sell(S)23K$6.45$147K288K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-063482) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML